Cardiovascular Prevention in Diabetes Mellitus No Magic Remedies

被引：0
|
作者：
Farmakis, Dimitrios [1 ]
Parissis, John [1 ]
Filippatos, Gerasimos [1 ]
机构：
[1] Univ Athens, Sch Med, Dept Cardiol 2, Heart Failure Unit,Attikon Univ Hosp, Athens 11523, Greece
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 63卷 / 19期
关键词：
ASPIRATION;
D O I：
10.1016/j.jacc.2013.12.039
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2053 / 2054
页数：4
相关论文
共 50 条
  • [41] PREVENTION OF DIABETES MELLITUS
    CAMERINIDAVALOS, RA
    MEDICAL CLINICS OF NORTH AMERICA, 1965, 49 (04) : 865 - +
  • [42] Diabetes Mellitus Prevention
    Allende-Vigo, Myriam Zaydee
    AMERICAN JOURNAL OF THERAPEUTICS, 2015, 22 (01) : 68 - 72
  • [43] The Prevention of Diabetes Mellitus
    Joslin, Elliott P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (02): : 190 - 190
  • [44] Fenofibrate for Cardiovascular Disease Prevention in Metabolic Syndrome and Type 2 Diabetes Mellitus
    Steiner, George
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (12A): : 28L - 33L
  • [45] Prevention of cardiovascular complications associated with diabetes mellitus: hospital emergency department involvement
    Agudo Villa, Teresa
    Alvarez-Rodriguez, Esther
    Caurel Sastre, Zaida
    Martin Martinez, Alfonso
    Merinero Palomares, Raul
    Alvarez Rodriguez, Virginia
    Portero Sanchez, Isabel
    EMERGENCIAS, 2015, 27 (03): : 150 - 154
  • [46] Diabetes Mellitus and Cardiovascular Prevention: The Role and the Limitations of Currently Available Antiplatelet Drugs
    Tufano, A.
    Cimino, E.
    Di Minno, M. N. D.
    Ierano, P.
    Marrone, E.
    Strazzullo, A.
    Di Minno, G.
    Cerbone, A. M.
    INTERNATIONAL JOURNAL OF VASCULAR MEDICINE, 2011, 2011
  • [47] Should a statin be routinely prescribed for primary prevention of cardiovascular disease in diabetes mellitus?
    Hackam, DG
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (08) : 857 - 857
  • [48] Cardiovascular prevention in diabetes mellitus. Is it appropriate to speak of moderate or intermediate risk?
    Martinez-Hervas, Sergio
    Real, Jose T.
    Carmena, Rafael
    Ascaso, Juan F.
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2024, 36 (02): : 80 - 85
  • [49] Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome
    Arca, Marcello
    DRUGS, 2007, 67 : 43 - 54
  • [50] Prevention of cardiovascular diseases, diabetes mellitus and chronic kidney diseases in general practice
    Nielen, M.
    Assendelft, P.
    Drenthen, T.
    van den Hombergh, P.
    van Dis, I
    Schellevis, F.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 20S - 20S
12345